VRP Verona Pharma Plc

 
TIDMVRP 
 
   LONDON, July 06, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) 
(Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical 
company focused on developing and commercializing innovative therapies 
for respiratory diseases, announces that it has issued 55,000 ordinary 
shares of 5 pence each (the "New Ordinary Shares") following the vesting 
of restricted stock units held by a former employee. 
 
   Application will be made to the London Stock Exchange for the New 
Ordinary Shares to be admitted to trading on AIM, with dealings expected 
to commence on July 10, 2020 ("Admission"). 
 
   Total voting rights 
 
   Following Admission, the Company will have a total of 106,536,006 
Ordinary Shares in issue each carrying one voting right. The Company 
does not hold any Ordinary Shares in Treasury. This figure of 
106,536,006 Ordinary Shares may be used by shareholders as the 
denominator for the calculations by which they will determine if they 
are required to notify their interest in, or a change to their interest 
in, the share capital of the Company under the FCA's Disclosure and 
Transparency Rules. 
 
   For further information, please contact: 
 
 
 
 
Verona Pharma plc                                     Tel: +44 (0)20 3283 4200 
Victoria Stewart, Director of Communications             info@veronapharma.com 
 
N+1 Singer (Nominated Adviser and UK Broker)          Tel: +44 (0)20 7496 3000 
Aubrey Powell / George Tzimas / Iqra Amin (Corporate 
 Finance) 
 Tom Salvesen (Corporate Broking) 
 
 
 
 
 
 
 

(END) Dow Jones Newswires

July 06, 2020 11:04 ET (15:04 GMT)

Verona Pharma (LSE:VRP)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Verona Pharma (LSE:VRP)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025